Common Contracts
6 similar Release Agreement contracts by Fulgent Diagnostics, Inc., Fulgent Genetics, Inc.
SEVERANCE AGREEMENTRelease Agreement • September 2nd, 2016 • Fulgent Genetics, Inc. • Services-medical laboratories • California
This SEVERANCE AGREEMENT (the “Agreement”), dated July 7, 2016, is by and among Fulgent Therapeutics LLC, a California limited liability company (the “Company”), Fulgent Diagnostics, Inc., a Delaware corporation (“HoldCo”) and Paul Kim (“Executive”).
SEVERANCE AGREEMENTRelease Agreement • September 2nd, 2016 • Fulgent Genetics, Inc. • Services-medical laboratories • California
This SEVERANCE AGREEMENT (the “Agreement”), dated July 7, 2016, is by and among Fulgent Therapeutics LLC, a California limited liability company (the “Company”), Fulgent Diagnostics, Inc., a Delaware corporation (“HoldCo”) and Ming Hsieh (“Executive”).
SEVERANCE AGREEMENTRelease Agreement • September 2nd, 2016 • Fulgent Genetics, Inc. • Services-medical laboratories • California
This SEVERANCE AGREEMENT (the “Agreement”), dated July 7, 2016, is by and among Fulgent Therapeutics LLC, a California limited liability company (the “Company”), Fulgent Diagnostics, Inc., a Delaware corporation (“HoldCo”) and Hanlin Gao (“Executive”).
SEVERANCE AGREEMENTRelease Agreement • July 15th, 2016 • Fulgent Diagnostics, Inc. • Services-medical laboratories • California
This SEVERANCE AGREEMENT (the “Agreement”), dated July 7, 2016, is by and among Fulgent Therapeutics LLC, a California limited liability company (the “Company”), Fulgent Diagnostics, Inc., a Delaware corporation (“HoldCo”) and Hanlin Gao (“Executive”).
SEVERANCE AGREEMENTRelease Agreement • July 15th, 2016 • Fulgent Diagnostics, Inc. • Services-medical laboratories • California
This SEVERANCE AGREEMENT (the “Agreement”), dated July 7, 2016, is by and among Fulgent Therapeutics LLC, a California limited liability company (the “Company”), Fulgent Diagnostics, Inc., a Delaware corporation (“HoldCo”) and Paul Kim (“Executive”).
SEVERANCE AGREEMENTRelease Agreement • July 15th, 2016 • Fulgent Diagnostics, Inc. • Services-medical laboratories • California
This SEVERANCE AGREEMENT (the “Agreement”), dated July 7, 2016, is by and among Fulgent Therapeutics LLC, a California limited liability company (the “Company”), Fulgent Diagnostics, Inc., a Delaware corporation (“HoldCo”) and Ming Hsieh (“Executive”).
